Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | Late market roundup: Stocks close mixed after Trump's Monday comments | ||
Di | UK earnings, trading statements calendar - next 7 days | ||
Di | Regent Acquisitions launches £109 million cash offer for Inspired | ||
Di | Focus Xplore appoints exploration consultants for upcoming programs | ||
Di | Fulcrum Metals identifies gallium at Teck-Hughes & Sylvanite projects | ||
Di | Valereum's £19 million investment deal with DMC falls through | ||
Di | IN BRIEF: Clean Power Hydrogen names new chief commercial officer | ||
Di | Gelion executes materials testing deal with battery manufacturer | ||
Di | Admiral agrees to sell US motor insurance business to JC Flowers | ||
Di | IN BRIEF: Mkango Resources appoints lead engineers for Texas project | ||
Di | BoE rate-setter says US tariffs likely to push down on inflation | ||
Di | IN BRIEF: Safestore CEO Vecchioli buys £1 million in shares in April | ||
Di | Braime gives uncertain outlook for 2025 amid tariffs as profit falls | ||
Di | IN BRIEF: Videndum expects to report lower revenue for 2024 | ||
Di | IN BRIEF: Fintel promotes Tim Clarke to senior independent director | ||
Di | IN BRIEF: Bunzl CFO Richard Howes buys £100,000 in shares | ||
Di | Lunchtime market roundup: Stocks mixed as sterling hits 7-month high | ||
Di | East Star Resources loss narrows as it eyes new targets for 2025 | ||
Di | IN BRIEF: Wise head of Banking sells 10,000 shares | ||
Di | AOTI oxygen therapy enters NHS supply chain framework deal | ||
Di | Arecor Therapeutics sees 'significant future growth' as revenue rises | ||
Di | Shield Therapeutics inks licencing agreement for iron deficiency drug | ||
Di | Celebrus shares fall as full-year revenue misses expectations | ||
Di | Oracle Power stock falls as placing to fund Australia, Pakistan works | ||
Di | AIM WINNERS & LOSERS: Celebrus revenue to fall short of guidance |